Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in Restless Legs Syndrome
NCT01061372Phase 3Withdrawn
- Sponsor
- Viatris
- Start
- May 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pregabalin in restless legs syndrome (RLS), sponsored by Viatris. Planned start May 2010; status: withdrawn.
02
Drugs
pregabalin
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT01061372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061372.